Shuangcheng Pharmaceutical: Changes to "Drug Production License," Authorized to Produce Sodium Ethambutol for Injection.

Shuangcheng Pharmaceutical announced that they have recently obtained a modified Drug Production License from the Hainan Provincial Drug Administration, allowing them to accept the commission of Shanghai Mengke Pharmaceutical to produce the injection of Etoposide Sodium. The production address is at the third workshop of lyophilized powder injections on Xingguo Road, Xiuying District, Haikou City. The other contents remain unchanged. The license is valid until August 7, 2030. This change is beneficial for optimizing the production structure and will not have a significant impact on performance in the short term.